FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
| PAGRX Fund | USD 106.83 1.63 1.55% |
Slightly above 53% of Aggressive Growth's investors are presently thinking to get in. The analysis of overall sentiment of trading Aggressive Growth Portfolio mutual fund suggests that some investors are interested at this time. Aggressive Growth's investing sentiment can be driven by a variety of factors including economic data, Aggressive Growth's earnings reports, geopolitical events, and overall market trends.
Aggressive |
Amgens Lumakras treatment, combined with Vectibix, is FDA-approved for KRAS G12C-mutated colorectal cancer.
Read at benzinga.com
 |
Aggressive Growth Fundamental Analysis
We analyze Aggressive Growth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aggressive Growth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aggressive Growth based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Aggressive Growth is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Aggressive Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aggressive Growth mutual fund to make a market-neutral strategy. Peer analysis of Aggressive Growth could also be used in its relative valuation, which is a method of valuing Aggressive Growth by comparing valuation metrics with similar companies.
Peers
Aggressive Growth Related Equities
| STRGX | Sterling Capital | 1.43 | ||||
| THPBX | Dreyfus Balanced | 0.50 | ||||
| PRVBX | Versatile Bond | 0.08 | ||||
| PRTBX | Short Term | 0.02 | ||||
| PRPFX | Permanent Portfolio | 0.11 |
Other Information on Investing in Aggressive Mutual Fund
Aggressive Growth financial ratios help investors to determine whether Aggressive Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aggressive with respect to the benefits of owning Aggressive Growth security.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |